864 Does Gleason score at initial diagnosis predict efficacy of abiraterone acetate (AA) therapy in patients with metastatic castration-resistant prostate cancer (mCRPC)? An analysis of AA phase 3 trials

✍ Scribed by Stöckle, M.; Flaig, T.; Ohlmann, C.H.; Scher, H.I.; De Bono, J.S.; Rathkopf, D.; Ryan, C.J.; Kheoh, T.; Li, J.; Todd, M.; Griffin, T.W.; Molina, A.; Fizazi, K.

• Book ID: 123552756
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 206 KB
• Volume: 13
• Category: Article
• ISSN: 1569-9056
• DOI: 10.1016/S1569-9056(14)60851-4